3[1]Reichen J.Liver function and pharmacological consideration in pathogenesis and treatment of portal hypertension.Hepatology,1990,11(6):1 066～1 078. 被引量：1
4[3]Jenkins SA,Baxter JN,Corbet WA,et al.Effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in pig and on Intravariceal pressure in man.Br J Surg,1985,75(12):1 009-1 012. 被引量：1
5[4]Barrioz T,Borderie C,Strock P,et al.Effects of octreotide on lower esophageal sphincted in patients with cirrhosis and portol hypertension.Dig Dis Sci,1998,43(7):1 566-1 571. 被引量：1
6[5]Cello JP.Octreotide therapy for variceal hemorrhage.Digestion,1993,54(suppl):21. 被引量：1
7[6]Mckee RF.Sandostatin therapy of acute oesophageal variceal bleeding.Digestion,1993,54(suppl):27. 被引量：1
8[9]Sung JJ,Chung SC,Lai CW,et al.Octreotide Infusion or emergency sclerotherapy for variceal heamorrhage.Lancet,1993,342:637-641. 被引量：1
